Work was conducted through 5 work packages. In the first, the expression analysis of the potential target for drug repurposing in PDAC was conducted for which the results were deposited into a public repository, and were presented in the form of one conference presentation. The fellow also gave a lecture at the University of Belgrade graduate course on the -omics technologies used in the REPANCAN project. In the second WP, the mechanisms of action of the selected agonists on PDAC were explored; the results were uploaded to a public repository and presented in a form of 4 poster presentations at international conferences. In the WP3 the potential of selected agonists to overcome resistance to standard chemotherapy were examined and the results were presented in a form of one conference talk and 3 poster presentations. In the WP4 an ex vivo pancreatic cancer organ model was established. The model was presented at an online international school on 3D tissue culture models and at a workshop for undergraduate students of the School of Biology, University of Belgrade. The fellow also gave a talk about the project at the COST action meeting on multidrug resistance and fellow’s graduate student presented the overall results as a poster at another international conference. In the WP5 a PDAC patient database was generated to perform retrospective analyses in order to determine whether selected agonists impact patient survival. During the fellowship, the fellow participated in outreach activities to promote careers in science, especially for women through video interviews for Science Calendar, Belgrade University student magazine and at COST actions meeting on gender equality.
